Health
Laboratory study suggests e-cigarette vanilla flavoring may alter early cell development
Researchers found vanillin disrupted human embryonic stem cells in laboratory dishes, though further research is needed to determine real-world human impacts.
The short version
- A study led by UC Riverside researchers found that vanillin, a common e-cigarette flavorant, altered human embryonic stem cell development in lab experiments.
- The chemical bound to the TRPV4 surface channel, causing stem cells to lose pluripotency and prematurely form endoderm tissue instead of other cell types.
- Because the study was conducted on lab-grown stem cells rather than in pregnant women, researchers emphasized the findings do not prove the same effects occur in human pregnancies.
- The study authors urged regulators to consider requiring e-cigarette makers to disclose full ingredient lists on product packaging.
Key facts
- The study, published in Human Reproduction on August 12, examined how exposure to vanillin affects human embryonic stem cells in a laboratory setting.[ScienceDaily]
- High concentrations of vanillin killed the stem cells, while lower concentrations caused them to lose pluripotency and differentiate into endoderm tissue.[ScienceDaily]
- Blocking the TRPV4 cell surface channel with an antagonist prevented vanillin from causing these developmental changes.[ScienceDaily]
- The research was funded in part by the California Institute of Regenerative Medicine and the Tobacco-Related Disease Research Program.[ScienceDaily]
What remains uncertain
- It remains unknown whether vanillin produces identical cell disruptions in developing human embryos inside pregnant women, as the trial was limited to in vitro stem cell models.[ScienceDaily]
- The study did not measure the cumulative or long-term impacts of extended vanillin exposure over days, weeks, or months.[ScienceDaily]
Sources
- A common vape flavoring may disrupt early embryo developmentScienceDaily - Health